Apellis Pharmaceuticals, Inc. - Common Stock (NQ:APLS)

25.55 +1.61 (+6.73%)

Streaming Delayed Price Updated: 1:35 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Apellis Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

19 20 Next >

Crude Oil Edges Lower; VCI Global Shares Spike Higher ↗

August 23, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Wednesday. The Dow traded up 0.40% to 34,425.29 while the NASDAQ rose 1.40% to 13,694.79. The S&P...

Via Benzinga

Topics Stocks

Airbnb Versus New York Regulations, Netflix Adds New US Users After Password Crackdown, Facebook Marketplace Under Regulatory Fire For Alleged Sale Of Recalled Items: Top Stories ↗

August 23, 2023

Wall Street Journal Airbnb Versus New York: What's Going On?

Via Benzinga

Apellis Soars 28% After Identifying Potential Culprit Behind Eye Drug Safety Woes ↗

August 23, 2023

Apellis has been investigating cases of eye inflammation following treatment with Syfovre.

Via Investor's Business Daily

Why Is Apellis Pharmaceuticals Stock Shooting Higher Today? ↗

August 23, 2023

Apellis Pharmaceuticals Inc (NASDAQ: APLS) released a comprehensive update regarding its Syfovre (pegcetacoplan injection) treatment for geographic atrophy (GA) secondary to age-

Via Benzinga

DKS Stock Alert: Dick’s Sporting Goods Continues to Drop After Worst Day on Record ↗

August 23, 2023

Dick's Sporting Goods (DKS) stock continues to see negative movement on Wednesday after experiencing a horrible fall on Tuesday.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 23, 2023

Via Benzinga

Why Is Foot Locker (FL) Stock Down 31% Today? ↗

August 23, 2023

Foot Locker (FL) stock is taking a beating on Wednesday after the athletic wear retailer released its Q2 earnings report.

Via InvestorPlace

Why Is AMC Entertainment (AMC) Stock Down 20% Today? ↗

August 23, 2023

AMC Entertainment (AMC) stock is falling on Wednesday as the movie theater company prepares for a stock conversion on Friday.

Via InvestorPlace

Why AMC Entertainment Shares Are Trading Lower By 21%; Here Are 20 Stocks Moving Premarket ↗

August 23, 2023

Gainers BioNexus Gene Lab Corp. (NASDAQ: BGLC) shares gained 48.5% to $2.05 in pre-market trading after jumping 30% on Tuesday.

Via Benzinga

Why Is Apellis Pharmaceuticals (APLS) Stock Up 23% Today? ↗

August 23, 2023

Apellis Pharmaceuticals (APLS) stock is on the rise Wednesday after the biopharmaceutical company announced an update on injection kits.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 23, 2023

It's time for another dive into the biggest pre-market stock movers as we break down all of the biggest news on Wednesday!

Via InvestorPlace

Urban Outfitters, Toll Brothers And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

August 23, 2023

U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 22, 2023

Via Benzinga

Apellis Provides Updates on Injection Kits and Rare Safety Events with SYFOVRE® (pegcetacoplan injection)

August 22, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

3 Sorry Pharma Stocks to Sell in August Before It’s Too Late ↗

August 22, 2023

Factors in the marketplace caused these companies to underperform, making them some of the top pharma stocks to sell.

Via InvestorPlace

APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Apellis Pharmaceuticals, Inc.

August 22, 2023

From Bernstein Liebhard LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against RTX, Eos, and Apellis and Encourages Investors to Contact the Firm

August 21, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Want to Get Rich? 3 Game-Changing Biotech Stocks to Buy Right Now ↗

August 21, 2023

Biotech stocks may offer some of the most explosive opportunities on the market. Here are three with major catalysts nearing.

Via InvestorPlace

NASDAQ: APLS Investor Alert: Lawsuit Alleges Misleading Statements by Apellis Pharmaceuticals, Inc. ↗

August 21, 2023

San Diego, CA -- (SBWIRE) -- 08/21/2023 -- An investor, who purchased shares of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), filed a lawsuit over alleged violations of Federal Securities Laws by...

Via SBWire

Topics Lawsuit

ROSEN, A TOP RANKED FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLS

August 19, 2023

WHY: NEW YORK, NY - (NewMediaWire) - August 19, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) between...

Via NewMediaWire

Topics Lawsuit

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apellis Pharmaceuticals, Inc. (APLS)

August 18, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 17, 2023

Via Benzinga

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apellis Pharmaceuticals, Inc. (APLS)

August 17, 2023

From Law Offices of Howard G. Smith

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against RTX, Eos, and Apellis and Encourages Investors to Contact the Firm

August 16, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, A LEADING LAW FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – APLS

August 16, 2023

From The Rosen Law Firm PA

Via GlobeNewswire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Apellis Pharmaceuticals, Inc. (APLS) Investors

August 15, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 14, 2023

Via Benzinga

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Apellis Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - APLS

August 14, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Apellis Pharmaceuticals, Inc. (APLS) Investors

August 14, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Apellis Pharmaceuticals, Inc. (APLS) Investors

August 14, 2023

From Law Offices of Howard G. Smith

Via Business Wire

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.